Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem

Neuropsychopharmacology

Volumn 17, Issue 5, 1997, Pages 326-341

  Austin, Mark C ^a,c   Rhodes, James L ^a   Lewis, David A ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Corticotropin releasing factor; Human; Immunocytochemistry; Locus coeruleus; Postmortem; Raphe; Ventral mesencephalon

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ADULT; AGED; ARTICLE; BRAIN STEM; CELLULAR DISTRIBUTION; DORSAL RAPHE NUCLEUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MENTAL DISEASE; MONOAMINERGIC NERVE; NEUROTRANSMISSION; PRIORITY JOURNAL; STRESS; SUBSTANTIA NIGRA;

ADULT; AGED; AXONS; BRAIN STEM; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; MESENCEPHALON; MIDDLE AGED; ORGAN SPECIFICITY; PONS; SEROTONIN;

EID: 0030727362     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00083-3     Document Type: Article

References (66)

1. Arató M, Bánki CM, Bissette G, Nemeroff CB (1989): Elevated CSF CRF in suicide victims. Biol Psychiatry 25:355-359
2. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146:730-736
3. Austin MC, Rice PM, Mann JJ, Arango V (1995): Localization of corticotropin-releasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus: An immunocytochemical and in situ hybridization study. Neuroscience 64:713-727
4. Boadle-Biber MC, Johannessen JN, Narasimhachari N, Phan T-H (1986): Tryptophan hydroxylase: Increase in activity by electrical stimulation of serotonergic neurons. Neurochem Int 8:83-92
5. Boadle-Biber MC, Corley KC, Graves L, Phan T-H, Rosecrans J (1989): Increase in the activity of tryptophan hydroxylase from cortex and midbrain of Fischer 344 rats in response to acute or repeated sound stress. Brain Res 482:306-316
6. Boadle-Biber MC, Singh VB, Corley KC, Phan T-H, Dilts RP (1993): Evidence that corticotropin-releasing factor within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat. Brain Res 628:105-114
7. Bowden DM, German DC, Poynter WD (1978): An autoradiographic, semistereotaxic mapping of major projections from locus coeruleus and adjacent nuclei in Macaca mulatta. Brain Res 145:257-276
8. Breier A, Wolkowitz OM, Pickar D (1991): Stress and schizophrenia. In Tamminga CA, Schulz SC (eds), Advances in Neuropsychiatry and Psychopharmacology, Vol 1: Schizophrenia Research. New York, Raven Press, pp 141-152
9. Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990): Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176-183
10. Chalmers DT, Lovenberg TW, DeSouza EB (1995): Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350
11. Chen R, Lewis KA, Perrin MH, Vale WW (1993): Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971
12. Cummings S, Eide R, Ells J, Lindall A (1983): Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochemical study. J Neurosci 3:1355-1368
13. De Souza EB (1987): Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution. J Neurosci 7:88-100
14. De Souza EB (1995): Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20:789-819
15. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ (1985): Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: An autoradiographic study. J Neurosci 5:3186-3203
16. Dunn AJ, Berridge CW (1987): Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 27:685-691
17. Emoto H, Tanaka M, Koga C, Yokoo H, Tsuda A, Yoshida M (1993): Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol Biochem Behav 45:419-422
18. Fischman AJ, Moldow RL (1982): Extrahypothalamic distribution of CRF-like irnmunoreactivity in the rat brain. Peptides 1:149-153
19. Foote SL, Cha CI (1988): Distribution of corticotropin-releasing-factor-like irnmunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): An immunohistochemical study. J Comp Neurol 276: 239-264
20. Forman SD, Bissette G, Yao J, Nemeroff CB, Van Kammen DP (1994): Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia. Schizophr Res 12:43-51
21. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Augerions P, Paul S, Oldfield EH, Cutler Jr GB, Chrousos GP (1986): Responses to corticotropin-releasing hormone in the hypercortisolism of depressives and Cushing's disease. N Engl J Med 314:1329-1342
22. Haber SN, Groenewegen HJ (1989): Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase irnmunoreactivity in the human substantia nigra. J Comp Neurol 290:53-68
23. Haber SN, Ryoo H, Cox C, Lu W (1995): Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: Comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin. J Comp Neurol 362:400-410
24. Halliday GM, Törk I (1991): Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey, and human. J Comp Neurol 252:423-445
25. Kalivas PW, Duffy P, Latimer LG (1987): Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242:757-763
26. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT (1993): The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Foundation Symposium 172:277-289
27. Lavicky J, Dunn AJ (1993): Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60:602-612
28. Lewis DA, Foote SL, Cha CI (1989): Corticotropin-releasing factor irnmunoreactivity in monkey neocortex: An immunohistochemical analysis. J Comp Neurol 290:599-613
29. Lewis DA, Sesack SR (1997): Dopamine systems in the primate brain. In Bloom FE, Björkland A, Hökfelt T (eds), Handbook of Chemical Neuroanatomy. The Primate Nervous System. New York, Elsevier Science, 13:261-373
30. Loughlin SE, Foote SL, Grzanna R (1986): Efferent projections of nucleus locus coeruleus: Morphologic subpopulations have different efferent targets. Neuroscience 18:307-319
31. Lovenberg TW, Liaw CW, Grigoriadis DE, Glevenger W, Chalmers DT, De Souza EB, Oltersdorf T (1995): Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840
32. Lynd-Balta E, Haber SN (1994a): The organization of midbrain projections to the ventral striatum in the primate. Neuroscience 59:609-623
33. Lynd-Balta E, Haber SN (1994b): The organization of midbrain projections to the striatum in the primate: Sensorimotor-related striatum versus ventral striatum. Neuroscience 59:625-640
34. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954-959
35. Melia KR, Duman RS (1991): Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 88:8382-8386
36. Merchenthaler I, Vigh S, Petrusz P, Schally AV (1982): Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165:385-396
37. Millan MA, Jacobowitz DM, Hauger RL, Catt KJ, Aguilera G (1986): Distribution of corticotropin-releasing factor receptors in primate brain. Proc Natl Acad Sci USA 83: 1921-1925
38. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988): Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577-579
39. Nordström P, Samuelsson M, Asberg M, Träskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L (1994): CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threatening Behav 24:1-9
40. Ono N, Bedran De Castro JC, McCann SM (1985): Ultrashortloop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. Proc Natl Acad Sci USA 82:3528-3531
41. Ordway GA, Streator Smith K, Haycock JW (1994): Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J Neurochem 62:680-685
42. Owens MJ, Nemeroff CB (1991): Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43: 425-473
43. Pammer C, Göres T, Palkovits M (1990): Peptidergic innervation of the locus coeruleus cells in the human brain. Brain Res 515:247-255
44. Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salamon MS, Mecheri G, Schatzberg AF (1994): Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biol Psychiatry 36:616-621
45. Pucak ML, Levitt JB, Lund JS, Lewis DA (1996): Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J Comp Neurol 376:614-630
46. Rivier C, Vale W (1983): Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305:325-327
47. Roth RH, Tam S-Y, Ida Y, Yang J-X, Deutch AY (1988): Stress and the mesocorticolimbic dopamine systems. Ann NY Acad Sci 537:138-147
48. Roy A (1993): Neuropeptides in relation to suicidal behavior in depression. Neuropsychobiology 28:184-186
49. Roy A, Agren H, Pickar D, Linnoila M, Doran AR, Cutler NR, Paul SM (1986): Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry 143:1539-1545
50. Roy A, De Jong J, Linnoila M (1989): Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. Arch Gen Psychiatry 46:609-612
51. Roy A, Karoum F, Pollack S (1992): Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide. Arch Gen Psychiatry 49:447-450
52. Schulz C, Lehnert H (1996): Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor: A microdialysis study. Neuroendocrinology 63: 454-458
53. Singh VB, Hao-Phan T, Corely KC, Boadle-Biber MC (1992): Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin releasing factor: Block by adrenalectomy, by RU 38486 and by bilateral lesions to the central nucleus of the amygdala. Neurochem Int 20:81-92
54. Smagin GN, Swiergiel AH, Dunn AJ (1995): Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res Bull 36:71-76
55. Stanford SC (1993): Monoamines in response and adaptation to stress. In Stanford SC, Salmon P (eds), Stress: From Synapse to Syndrome. London, Academic Press, pp 281-331
56. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983): Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36: 165-186
57. Valentino RJ, Foote SL, Aston-Jones G (1983): Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363-367
58. Valentino RJ, Foote SL (1987): Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology 45:28-36
59. Valentino RJ, Foote SL (1988): Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci 8:1016-1025
60. Valentino RJ, Wehby RG (1988): Corticotropin-releasing factor: Evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress. Neuroendocrinology 48:674-677
61. Valentino RJ, Page ME, Curtis AL (1991): Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 555:25-34
62. Van Bockstaele EJ, Colago EEO, Valentine RJ (1996): Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 364:523-534
63. Van Praag HM (1980): Central monoamine metabolism in depressions. II. Catecholamines and related compounds. Compr Psychiatry 21:448-54
64. Ventura I, Nuechterlein KH, Hardesty JP, Gitlin M (1992): Life events and schizophrenic relapse after withdrawal of medication. Br J Psychiatry 161:615-620
65. Waterhouse BD, Lin C-S, Burne RA, Woodward DJ (1982): The distribution of neocortical projection neurons in the locus coeruleus. J Comp Neural 217:418-431
66. Widerlöv E, Bissette G, Nemeroff CB (1988): Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. J Affective Disord 14:99-107